If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals.

Slides:



Advertisements
Similar presentations
Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups funded by the European Commissions Directorate General for Health.
Advertisements

Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Needle Replacement in Scottish Prisons: Practical Issues for Implementation Stephen Heller-Murphy Addiction Policy Development Scottish Prison Service.
Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.
Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Needle and syringe programmes in prisons
Scottish Prisons and the Hepatitis C Challenge Scottish Drugs Forum February 2007 Andrew Fraser.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
A Call for Action HIV/AIDS & Hepatitis C in Irish Prisons Irish Penal Reform Trust & Merchants Quay Ireland by Rick Lines, MA July 26, 2002.
Harm Reduction in Prisons: Prisoners’ Rights are Human Rights Rick Lines, MA Executive Director, Irish Penal Reform Trust December 11 th 2003.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
Harm Reduction and Drug Policy in Western European Prisons “HIV, Hepatitis C, and Harm Reduction in prisons: Evidence, Best Practice and Human Rights“
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Sex work among people who inject drugs in England, Wales & Northern Ireland: Findings from a National Survey of Health Harms and Behaviours Sara Croxford,
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Opiate Substitution Treatment and Harm Reduction in prisons: the Geneva model PD Dr Hans Wolff University Hospitals Geneva
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Community Paralegals Developing Peer Legal Support for People Who Use Drugs in Indonesia Bridging the Gaps Indonesian Drug Users Network (PKNI)
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Treatment of drug addiction in prisons
At the frontier of drug harm reduction Prisoners’ rights to health & safety David McDonald Visiting Fellow National Centre for Epidemiology and Population.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Results from the Spanish experience: A comprehensive approach to HIV and HCV in prisons MERCEDES GALLIZO LLAMAS Secretary-General of Spanish Prison Administration.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Annual report 2010: the state of the drugs problem in Europe.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
Drug Use and Hepatitis C Are we mindful of the gaps? Dave Liddell, SDF.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Route transition interventions encouraging switching from injecting and preventing its adoption welsh needle exchange forum, national conference cardiff.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
My healthy life Helen Mycock – Mencap Health programme manager.
Module 1 General introduction to substitution treatment.
Harm Reduction International
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
Jennifer R. Havens, PhD, MPH Associate Professor
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
1 NTA More treatment, better treatment, fairer treatment National injecting conference Annette Dale-Perera Director of Quality.
19 June 2007 Prison & Health Expert Meeting Paris Drugs and prisons DG SANCO C4 N. GRENIER.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
The Canadian Correctional Public Health Program Prison Health Expert Group Sixth Meeting Oslo, Norway September 30, 2008.
Health in Prisons Project Oslo, 24 November 2009 Lars Moller Regional Adviser a.i. World Health Organization Regional Office for Europe Health in Prisons.
Services and C Leon Wylie Lead Officer Hepatitis Scotland.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
MODULE 3 Harm reduction advocacy
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
General Situation (Overview)
Addressing Drug Use Together Through a Health Based Approach:
No one gets left behind: Addressing the hidden burden of hepatitis C related advanced liver disease in PWID in the community John S Lambert, MD, PhD.
Reitox National Focal Point National Bureau for Drug Prevention
People who inject drugs
Access to Services in Prison and Beyond
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Towards a Conducive Legal and Structural Environment
Myanmar Last Update: November 2014.
Blood borne viral hepatitis action in Wales
German Drug and Addiction Policy
Presentation transcript:

If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals (FDAP) and European Association for the Treatment of Addiction (EATA) Leicester, 16 th Feb 2006 Neil Hunt Chair, UK Harm Reduction Alliance Director of Research, KCA Honorary Senior Research Associate, EISS, University of Kent

…this would be fully implemented “Healthcare in prisons should promote the health of prisoners; identify prisoners with health problems; assess their needs and deliver treatment or refer to other specialist services as appropriate. It should also continue any care started in the community contributing to a seamless service and facilitating throughcare on release.” The Future Organisation of Prison Health Care Report by the Joint Prison Service & NHS Executive Working Group Dept of Health (1999)

Two important gaps Opioid substitution treatment –Patchy provision at best Needle exchange –Pilot work on discharge from Scottish prisons But…to what extent are they feasible and how well do they work in prisons?

Evidence: opioid substitution treatment in prisons Heroin injecting and syringe sharing reduced in Australia Dolan et al (2003) A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.. Drug and Alcohol Dependence. 72: Heroin use reduced in Puerto Rico Heimer et al (2005) Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico. Drug and Alcohol Dependence. Retention in MMT associated with reduced mortality, re-incarceration rates and hepatitis C infection in Australia Dolan et al (2005) Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 6: And forthcoming study of methadone treatment in Scottish prisons

Methadone treatment also available in… Switzerland Germany Spain

Evidence: needle exchange in prisons Stover & Nelles (2003) Review of 10 years experience in 46 prisons in 4 countries Results did not support fears that commonly arise in the start-up of implementation of Needle Exchange Programmes in Prisons. Syringe distribution was not followed by an increase in drug use or injection drug use. Syringes were not misused, and disposal of used syringes was uncomplicated. Sharing of syringes among drug users reduced. Stover and Nelles (2003) Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy. 14:

Evidence: needle exchange in prisons Lines et al (2004) Review of evidence from 6 countries (Switzerland, Germany, Spain, Moldova, Kyrgyzstan, Belarus) Do not endanger staff or prisoner safety, and in fact, make prisons safer places to live and work. Do not increase drug consumption or injecting. Reduce risk behaviour and disease (including HIV and HCV) transmission. Have other positive outcomes for the health of prisoners. Have been effective in a wide range of prisons. Have successfully employed different methods of needle distribution to meet the needs of staff and prisoners in a range of prisons. This report also provides detailed accounts of implementation issues within prisons Lines et al (2004) Prison needle exchange: lessons from a comprehensive review of international evidence and experience. Canadian HIV/AIDS Legal Network

Models that have been used Hand-to-hand distribution by prison nurse and/or physician Hand-to-hand distribution by peer outreach workers Hand-to-hand distribution by external agencies/health workers Automated dispensing machines

Treatment in prison: expected best practice WHO, UNAIDS, UNODC (2004) “The evidence shows that such programmes should include all the measures against HIV transmission which are carried out in the community outside prisons, including HIV/AIDS education, testing and counselling performed on a voluntary basis the distribution of clean needles, syringes and condoms, and drug-dependence treatment, including substitution treatment. All these interventions have proved effective in reducing the risk of HIV transmission in prisons. They have also been shown to have no unintended negative consequences.” WHO, UNAIDS, UNODC (2004) Policy Brief: reduction of HIV transmission in prisons. Available

Is there a need in the UK?

England and Wales Representative sample from 8/135 prisons Weild et al. (2000) Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey Communicable Disease and Public Health. 2: Ever injected n (%) First injected in prison (injectors) n (%) Ever injected in prison (injectors) n (%) Shared in prison (prison injectors) n (%) Male n = (24%)36 (6%)195 (31%)147 (75%) Female n = (29%)3 (3%)29 (26%)20 (69%) Young offender n = (4%)1 (3%)6 (20%)3(50%)

Scotland (15 prisons) May/June 2005 (77% response rate from ALL Scottish prisoners) Half of prisoners (50%) had used drugs in prison Three quarters (76%) reported decreased drug use in prison 17% reported increased drug use A third (34%) had used drugs in prison in the past month 67% who used drugs in the past month used heroin 126 (3%) reported injecting in prison in the last month. 78 (62%) prisoners had shared their injecting equipment Scottish Prison Service

Northern Ireland (3 prisons) March to November 2005 –Committed on drug related charges –Passive dog indications among visitors –Dependent on committal – Heroin 72 –Heroin finds – 18.2g + 14 tablets –Needle finds - none Paucity of data –History of injecting? –Injected/used heroin in prison? –Shared injecting equipment in prison? Northern Ireland Prison Service Drug Report

So, there does seem to be some need.

Services need to reflect the vulnerability and particular circumstances of prisoners. For example: –Prisoners with serious mental health problems –Prisoners assessed as presenting a serious risk of violence –Prisoners who use prison as a life event that enables abstinence –Prisoners are subject to a far higher level of surveillance and control But…prisons are different to the wider community

Services have to be adapted to reflect the requirements of a secure environment –Prisons have a duty of care that differentiates them from community services –Optimum models of service provision do not necessarily translate across from community services directly And…

I think this all means… Protecting the interests of those who use the prison environment constructively as a relatively drug-free environment Drawing on best evidence of ‘what works’ in prisons elsewhere Only a fool would pretend we have all the answers

So, if I ruled the world… We would roll out opioid substitution treatment (i.e. methadone AND buprenorphine treatment) across UK prisons vigorously We would roll out needle exchange, but more cautiously We would simultaneously undertake a rigorous and comprehensive programme of quantitative and qualitative evaluation

Reference summary Dept of Health (1999) The Future Organisation of Prison Health Care Report by the Joint Prison Service & NHS Executive Working Group. Dolan et al (2003) A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.. Drug and Alcohol Dependence. 72: Heimer et al (2005) Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico. Drug and Alcohol Dependence. Dolan et al (2005) Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 6: Stover and Nelles (2003) Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy. 14: Lines et al (2004) Prison needle exchange: lessons from a comprehensive review of international evidence and experience. Canadian HIV/AIDS Legal Network ternational_evidence_and_experience.pdfhttp:// ternational_evidence_and_experience.pdf WHO, UNAIDS, UNODC (2004) Policy Brief: reduction of HIV transmission in prisons. Weild et al. (2000) Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey Communicable Disease and Public Health. 2: Scottish Prison Service 2005 National Prisoner Survey Northern Ireland Prison Service Drug Report

Neil Hunt e: t: m: